Optimal loading dose of warfarin for the initiation of oral anticoagulation (Q24202077)

David Keeling

5

0 references

Rafael Perera

Rafael Perera

10

1 reference

ORCID Public Data File 2021

Richard Hobbs

9

FD Richard Hobbs

0 references

David Nunan

3

David Nunan

0 references

author name string

Kamal R Mahtani

1

0 references

Carl J Heneghan

2

0 references

Clare Bankhead

4

0 references

Alison M Ward

6

0 references

Sian E Harrison

Cochrane Database of Systematic Reviews

7

0 references

publication date

12 December 2012

0 references

published in

0 references

cites work

Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

A randomized controlled trial of genotype-based Coumadin initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

A randomized trial comparing 5-mg and 10-mg warfarin loading doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Pharmacodynamics of uniform versus nonuniform warfarin dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Initiation of oral anticoagulant therapy in orthopedic and surgical patients: an algorithm compared with routine dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Optimizing the efficacy and safety of oral anticoagulant therapy: high-quality dose management, anticoagulation clinics, and patient self-management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Warfarin induced skin necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Recommendations for patients undertaking self management of oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Optimal loading dose for the initiation of warfarin: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Safe introduction of warfarin for thrombotic prophylaxis in atrial fibrillation requiring only a weekly INR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Pharmacogenomics--ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

The largest prospective warfarin-treated cohort supports genetic forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Personalizing health care--is this the right time for warfarin?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Protein C response to induction of warfarin treatment after coronary bypass operation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Estimation of the warfarin dose with clinical and pharmacogenetic data

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Guidelines on oral anticoagulation with warfarin - fourth edition

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Standardised initial warfarin treatment: evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Flexible induction dose regimen for warfarin and prediction of maintenance dose

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021

Warfarin: Less May Be Better

1 reference

https://api.crossref.org/works/10.1002/14651858.CD008685.PUB2

7 January 2021